Abstract During the past two decades, a growing interest surrounding the interaction between microbe-associated molecular patterns (MAMPs) and pattern recognition receptors has occurred. This attention is now driven alongside bacterial-derived metabolites, which impact immune cell differentiation and function. Hence, this review introduces the term meta-MAMP as a means to classify the microbial derived-metabolites, which influence the immune response by affecting specific cellular processes. We discuss two prominent examples of meta-MAMPs: the first, rapamycin (isolated from Streptomyces), was discovered in the 1970s and since then has been thoroughly studied. The second, soraphen A (isolated from Myxobacteria), was discovered in the early 1990s but only recently identified as a promising immunomodulator. Both meta-MAMPs are similar in their remarkable capacity to modulate T cell fate by targeting key metabolic pathways triggered upon T cell activation. In this context, we highlight the progress made in the field of immunometabolism and the possibility of modulating metabolic pathways such as cellular fatty acid metabolism as a strategy for immunomodulation. We focus on the use of microbial metabolites as auspicious agents for T cell fate modulation.
%0 Journal Article
%1 Freitag2015
%A Castro, C N
%A Freitag, J
%A Berod, L
%A Lochner, M
%A Sparwasser, T
%D 2015
%E Immunol, Mol
%J Mol Immunol
%K sparwasser
%N 2 Pt C
%P 575-584
%T Microbe-associated immunomodulatory metabolites: Influence on T cell fate and function
%V 68
%X Abstract During the past two decades, a growing interest surrounding the interaction between microbe-associated molecular patterns (MAMPs) and pattern recognition receptors has occurred. This attention is now driven alongside bacterial-derived metabolites, which impact immune cell differentiation and function. Hence, this review introduces the term meta-MAMP as a means to classify the microbial derived-metabolites, which influence the immune response by affecting specific cellular processes. We discuss two prominent examples of meta-MAMPs: the first, rapamycin (isolated from Streptomyces), was discovered in the 1970s and since then has been thoroughly studied. The second, soraphen A (isolated from Myxobacteria), was discovered in the early 1990s but only recently identified as a promising immunomodulator. Both meta-MAMPs are similar in their remarkable capacity to modulate T cell fate by targeting key metabolic pathways triggered upon T cell activation. In this context, we highlight the progress made in the field of immunometabolism and the possibility of modulating metabolic pathways such as cellular fatty acid metabolism as a strategy for immunomodulation. We focus on the use of microbial metabolites as auspicious agents for T cell fate modulation.
@article{Freitag2015,
abstract = {Abstract During the past two decades, a growing interest surrounding the interaction between microbe-associated molecular patterns (MAMPs) and pattern recognition receptors has occurred. This attention is now driven alongside bacterial-derived metabolites, which impact immune cell differentiation and function. Hence, this review introduces the term meta-MAMP as a means to classify the microbial derived-metabolites, which influence the immune response by affecting specific cellular processes. We discuss two prominent examples of meta-MAMPs: the first, rapamycin (isolated from Streptomyces), was discovered in the 1970s and since then has been thoroughly studied. The second, soraphen A (isolated from Myxobacteria), was discovered in the early 1990s but only recently identified as a promising immunomodulator. Both meta-MAMPs are similar in their remarkable capacity to modulate T cell fate by targeting key metabolic pathways triggered upon T cell activation. In this context, we highlight the progress made in the field of immunometabolism and the possibility of modulating metabolic pathways such as cellular fatty acid metabolism as a strategy for immunomodulation. We focus on the use of microbial metabolites as auspicious agents for T cell fate modulation. },
added-at = {2015-09-09T11:15:02.000+0200},
author = {Castro, C N and Freitag, J and Berod, L and Lochner, M and Sparwasser, T},
biburl = {https://www.bibsonomy.org/bibtex/2eee1942a67ee029dfa897a2aeac44477/sparwasser},
editor = {Immunol, Mol},
interhash = {00856a32b54da976873c7b27aa7587be},
intrahash = {eee1942a67ee029dfa897a2aeac44477},
journal = {Mol Immunol},
keywords = {sparwasser},
number = {2 Pt C},
pages = {575-584},
pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/26320629},
timestamp = {2016-01-11T11:40:26.000+0100},
title = {Microbe-associated immunomodulatory metabolites: Influence on T cell fate and function },
volume = 68,
year = 2015
}